• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Apotex`s Generic Bromfenac Sodium Receives Approval in US

    FDA

    Alembic`s Generic Bromfenac Sodium Receives Approval in US

    FDA

    Lupin`s Generic Bromfenac Sodium Receives Approval in the U.S.

    FDA

    Lupin`s Generic Bromfenac Sodium Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Bromfenac Sodium Receives Approval in the U.S.

    FDA

    Alembic Pharmaceuticals` Generic Bromfenac Sodium Receives Approval In US

    FDA

    Innopharma Licensing`s Generic Bromfenac Sodium Receives Approval In US

    FDA

    Bromsitetm (bromfenac ophthalmic Solution): Sun Pharma Global v. Lupin Limited

    PATENT LITIGATION

    Paddock Labs Generic Bromfenac Sodium Receives Tentative Approval In US

    FDA

    FDA Confirms Paragraph IV Patent Challenge of Bromsite (Bromfenac Sodium) Ophthalmic Solution

    FDA

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.